Sep 23, 2013 at 09:56 | Source: Moneycontrol.com
Genzyme, a fully-owned subsidiary of drug major Sanofi-Aventis, alleged that the Indian drug maker infringed patents of its blockbuster cancer drug Mozobil on three counts.
Sep 22, 2013 at 13:58 | Source: PTI
In its petition filed in the District Court of Delaware, Genzyme alleged that DRL intimated though a letter that it had submitted an Abbreviated New Drug Application with US FDA seeking approval to engage in the commercial manufacture, importation, use, and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil drug.
Sep 16, 2013 at 15:54 | Source: Moneycontrol.com
Pharma major, Lupin, announced today that it has received final approval for its Zolpidem Tartrate Extended-release tablets USP, 6.25 mg and 12.5 mg from the United States Food and Drugs Administration (FDA) to market a generic version of Sanofi Aventis, US, LLCs (Sanofi) Ambien CR Extended-release tablets, 6.25 mg and 12.5 mg.
Jun 26, 2013 at 18:46 | Source: Moneycontrol.com
The stock hit 5 percent upper circuit limit on Wednesday following a report that companies like Sanofi Aventis, Novartis and GlaxoSmithKline were in the race to buy out the company's domestic formulations business.
Jun 26, 2013 at 12:12 | Source: Moneycontrol.com
The report states that Sanofi and GSK have put in non-binding bids and Novartis has signed a non-disclosure agreement to acquire the domestic formulations business of Elder Pharma.
Jun 16, 2013 at 21:30 | Source: PTI
Concerned over spate of acquisitions of domestic pharma firms by multinationals, the Department of Industrial Policy and Promotion will soon send a comprehensive proposal to the PMO for review of the current policy for FDI in existing drug companies.
Feb 19, 2013 at 22:31 | Source: PTI
Sanofi India (previously known as Aventis Pharma) on Tuesday said it aims to double its consumer healthcare business in the next five years
Feb 15, 2013 at 15:43 | Source: Moneycontrol.com
The Andhra Pradesh High Court (HC) today said that French drug giant Sanofi Aventis need not pay capital gain tax as demanded by Income Tax (I-T) department for acquisition of Shantha Biotech in 2009.
Oct 17, 2012 at 15:00 | Source: PTI
Pharma major Lupin today said its subsidiary, Lupin Pharmaceuticals, has received approval for its Irbesartan tablets from US Food and Drugs Administration to market a generic version of Sanofi Aventis's Avapro tablets.
Oct 17, 2012 at 14:51 | Source: PTI
Lupin Pharmaceuticals has received approval for its Irbesartan tablets, used for treating hypertension, from US Food and Drugs Administration (USFDA) to market a generic version of Sanofi Aventis's Avapro tablets.